0001752724-19-001334.txt : 20190111 0001752724-19-001334.hdr.sgml : 20190111 20190111170303 ACCESSION NUMBER: 0001752724-19-001334 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181031 FILED AS OF DATE: 20190111 DATE AS OF CHANGE: 20190111 EFFECTIVENESS DATE: 20190111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER DISCOVERY MID CAP GROWTH FUND CENTRAL INDEX KEY: 0001121966 IRS NUMBER: 134134341 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-10071 FILM NUMBER: 19522821 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER SMALL- & MID-CAP GROWTH FUND DATE OF NAME CHANGE: 20100630 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER EMERGING GROWTH FUND DATE OF NAME CHANGE: 20000815 N-CEN 1 primary_doc.xml X0101 N-CEN LIVE 0001121966 XXXXXXXX 811-10071 N-1A true Oppenheimer Discovery Mid Cap Growth Fund 811-10071 0001121966 549300I9P3REZXOLPD76 6803 South Tucson Way Centennial 80112 US-CO US 3037683200 OppenheimerFunds, Inc. 6803 S. Tucson Way Centennial 80112-3924 3037683200 The accounts, books and other documents required to be maintained by Registrant pursuant to Section 31(a) of the Investment Company Act of 1940 and rules promulgated thereunder. Y N N-1A 1 Y Edmund P. Giambastiani, Jr. N/A N Joanne Pace N/A N Arthur P. Steinmetz N/A Y Mary F. Miller N/A N Elizabeth Krentzman N/A N Joel W. Motley N/A N Beth Ann Brown N/A N Brian F. Wruble N/A N Daniel S. Vandivort N/A N Mary Ann Picciotto 004235357 225 Liberty Street New York 10281-1008 XXXXXX N N N N N N OPPENHEIMERFUNDS DISTRIBUTOR, INC. 8-22992 000007834 N/A Y N KPMG LLP 185 5493003PVCIGA21K0K42 N N N N N N Oppenheimer Discovery Mid Cap Growth Fund S000007009 549300I9P3REZXOLPD76 Y 5 0 1 N/A N N N N N/A N/A N/A Rule 17a-7 (17 CFR 270.17a-7) Rule 22d-1 (17 CFR 270.22d-1) Y Y N N OFI Global Asset Management, Inc. 801-76771 000161556 549300LIDDYHF0BY6S79 N OPPENHEIMERFUNDS, INC. 801-08253 000104983 PDOAIGLBY74951MQ1C36 Y N OFI Global Asset Management, Inc. 84-06477 549300LIDDYHF0BY6S79 Y N N Thomson Reuters Markets, LLC 20-4530702 Federal Tax ID Number N N Brown Brothers Harriman & Co 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Shareholder Services, Inc. 84-00907 SEC File number Y Y N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N N N GOLDMAN, SACHS & CO. 008-00129 000000361 FOR8UP27PHTHYVLBNG30 36612.49000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 68655.93000000 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 31057.41999999 ROBERT W. BAIRD & CO. INCORPORATED 008-00497 000008158 549300772UJAHRD6LO53 41813.43999999 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 60094.52000000 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 57856.55000000 SANFORD C. BERNSTEIN & CO., LLC 008-52942 000104474 549300I7JYZHT7D5CO04 97337.17000000 SUNTRUST ROBINSON HUMPHREY, INC. 008-17212 000006271 CSVTK36R0PNGXEM7NS14 33313.24000000 LIQUIDNET, INC. 008-52461 000103987 213800HSKBBO1GCVRG79 48500.65999999 RAYMOND JAMES & ASSOCIATES, INC. 008-10999 000000705 U4ONQX15J3RO8XCKE979 45784.28000000 887793.17000000 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 4165942.50000000 GOLDMAN, SACHS & CO. 008-00129 000000361 FOR8UP27PHTHYVLBNG30 2078160.50000000 WELLS FARGO SECURITIES, LLC 008-22947 000126292 VYVVCKR63DVZZN70PB21 1073765.00000000 CITIGROUP GLOBAL MARKETS INC. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 1313996.50000000 JMP SECURITIES LLC 008-39613 000022208 549300IDHEFHQ741DW68 475533.50000000 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 622032.00000000 UBS SECURITIES LLC 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 542228.00000000 RBC CAPITAL MARKETS, LLC 008-45411 000031194 549300LCO2FLSSVFFR64 1114761.00000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 3386737.00000000 DEUTSCHE BANK SECURITIES INC. 008-17822 000002525 DL6FFRRLF74S01HE2M14 986263.50000000 19181973.00000000 Y 1170564313.81422000 Committed 1950000000.00000000 N N false false true false false false INTERNAL CONTROL RPT 2 ncen-oppdiscoverymidcapgrowt.htm ncen-oppdiscoverymidcapgrowt.htm - Generated by SEC Publisher for SEC Filing

Report of Independent Registered Public Accounting Firm

The Board of Trustees and Shareholders
Oppenheimer Discovery MidCapGrowthFund:

In planning and performing our audit of the financial statements of Oppenheimer Discovery Mid Cap Growth Fund (the “Fund”) as of and for the year ended October 31, 2018, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

Management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject tothe risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that


 

might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of October 31, 2018.

This report is intended solely for the information and use of management and the Board of Trustees of Oppenheimer Discovery Mid Cap Growth Fund and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties.

KPMG LLP

Denver, Colorado
December 21, 2018